PL360531A1 - Sposoby syntezy aplidyny, nowe przeciwnowotworowepochodne aplidyny oraz sposoby wytwarzania i użycia tych pochodnych - Google Patents

Sposoby syntezy aplidyny, nowe przeciwnowotworowepochodne aplidyny oraz sposoby wytwarzania i użycia tych pochodnych

Info

Publication number: PL360531A1
Authority: PL; Poland
Prior art keywords: methods; aplidine; making; new antitumoral; derivatives
Prior art date: 2000-06-30

Application number

PL36053101A

Other languages

English (en)

Other versions

PL208651B1 (pl

Inventor

Ignacio Rodriguez

Concepcion Polanco

Felix Cuevas

Paloma Mandez

Carmen Cuevas

Pilar Gallego

Simon Munt

Ignacio Manzanares

Original Assignee

Pharma Mar S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-30

Filing date

2001-07-02

Publication date

2004-09-06

2000-06-30 Priority claimed from GB0016148A external-priority patent/GB0016148D0/en

2001-02-15 Priority claimed from GB0103750A external-priority patent/GB0103750D0/en

2001-07-02 Application filed by Pharma Mar S.A. filed Critical Pharma Mar S.A.

2004-09-06 Publication of PL360531A1 publication Critical patent/PL360531A1/pl

2011-05-31 Publication of PL208651B1 publication Critical patent/PL208651B1/pl

Links

UUSZLLQJYRSZIS-LXNNNBEUSA-N plitidepsin Chemical compound CN([C@H](CC(C)C)C(=O)N[C@@H]1C(=O)N[C@@H]([C@H](CC(=O)O[C@H](C(=O)[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(OC)=CC=2)C(=O)O[C@@H]1C)C(C)C)O)[C@@H](C)CC)C(=O)[C@@H]1CCCN1C(=O)C(C)=O UUSZLLQJYRSZIS-LXNNNBEUSA-N 0.000 title abstract 2
230000000259 anti-tumor effect Effects 0.000 title 1
238000000034 method Methods 0.000 title 1
229950008499 plitidepsin Drugs 0.000 title 1
108010049948 plitidepsin Proteins 0.000 title 1
238000010189 synthetic method Methods 0.000 title 1
206010028980 Neoplasm Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Crystallography & Structural Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pyrrole Compounds (AREA)

PL360531A 2000-06-30 2001-07-02 Pochodne aplidyny o działaniu przeciwnowotworowym PL208651B1 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0016148A GB0016148D0 (en)	2000-06-30	2000-06-30	Synthetic methods for aplidine and new antitiumoral derivatives
GB0103750A GB0103750D0 (en)	2001-02-15	2001-02-15	Synthetic methods for aplidine and new antitumoral derivatives methods of making and using them
PCT/GB2001/002901 WO2002002596A2 (en)	2000-06-30	2001-07-02	Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them

Publications (2)

Publication Number	Publication Date
PL360531A1 true PL360531A1 (pl)	2004-09-06
PL208651B1 PL208651B1 (pl)	2011-05-31

Family

ID=26244577

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL360531A PL208651B1 (pl)	2000-06-30	2001-07-02	Pochodne aplidyny o działaniu przeciwnowotworowym

Country Status (25)

Country	Link
US (2)	US7348310B2 (pl)
EP (1)	EP1294747B1 (pl)
JP (1)	JP5289662B2 (pl)
KR (1)	KR100866056B1 (pl)
CN (2)	CN1449408A (pl)
AT (1)	ATE393775T1 (pl)
AU (1)	AU6769801A (pl)
BR (1)	BRPI0112375B8 (pl)
CA (1)	CA2414609C (pl)
CY (1)	CY1108549T1 (pl)
CZ (1)	CZ304204B6 (pl)
DE (1)	DE60133817T2 (pl)
DK (1)	DK1294747T3 (pl)
ES (1)	ES2305083T3 (pl)
HK (1)	HK1052940B (pl)
HU (1)	HU228998B1 (pl)
IL (2)	IL153680A0 (pl)
MX (1)	MXPA03000202A (pl)
NO (1)	NO334096B1 (pl)
NZ (1)	NZ523367A (pl)
PL (1)	PL208651B1 (pl)
PT (1)	PT1294747E (pl)
SI (1)	SI1294747T1 (pl)
UA (1)	UA76718C2 (pl)
WO (1)	WO2002002596A2 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030148933A1 (en)	1990-10-01	2003-08-07	Pharma Mar S.A.	Derivatives of dehydrodidemnin B
GB9803448D0 (en)	1998-02-18	1998-04-15	Pharma Mar Sa	Pharmaceutical formulation
CZ302498B6 (cs) *	1999-11-15	2011-06-15	Pharma Mar, S. A.	Farmaceutický prípravek obsahující aplidin pro lécení rakovinových onemocnení
US6509315B1 (en)	2000-04-07	2003-01-21	The Trustees Of The University Of Pennsylvania	Didemnin analogs and fragments and methods of making and using them
CA2405779A1 (en)	2000-04-07	2001-10-18	The Trustees Of The University Of Pennsylvania	Tamandarin and didemnin analogs and methods of making and using them
UA76718C2 (uk)	2000-06-30	2006-09-15	Фарма Мар, С.А.	Протипухлинні похідні аплідину
IL155273A0 (en)	2000-10-12	2003-11-23	Pharma Mar Sa	Pharmaceutical compositions comprising an aplidine compound
EP1620117A4 (en)	2003-03-12	2009-07-29	Pharma Mar Sa	IMPROVED ANTITUMORAL TREATMENTS
AU2004218883B2 (en)	2003-03-12	2009-10-01	Dana-Farber Cancer Institute, Inc.	Aplidine for multiple myeloma treatment
JP2006523214A (ja)	2003-03-21	2006-10-12	ジユーリー，マデレーン・エム	タマンダリン類似物およびこれらのフラグメントそして製造方法および使用方法
EP1942944A2 (en) *	2005-10-31	2008-07-16	Genentech, Inc.	Macrocyclic depsipeptide antibody-drug conjugates and methods
WO2007101235A2 (en) *	2006-02-28	2007-09-07	Pharma Mar, S.A.	Improved antitumoral treatments
AU2008313627A1 (en) *	2007-10-19	2009-04-23	Pharma Mar, S.A.	Improved antitumoral treatments
CA2717409A1 (en) *	2008-03-07	2009-09-11	Pharma Mar, S.A.	Improved anticancer treatments
WO2011020913A2 (en)	2009-08-21	2011-02-24	Pharma Mar, S.A.	Cyclodepsipeptide antiviral compounds
WO2012042123A1 (fr) *	2010-09-10	2012-04-05	Sanofi	Polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree
KR102491180B1 (ko)	2017-04-27	2023-01-20	파르마 마르 에스.에이.	항종양 화합물
US20230158104A1 (en)	2020-03-02	2023-05-25	Pharma Mar, S.A.	Compounds for use in autoimmune conditions
CN115461067A (zh)	2020-03-02	2022-12-09	法马马有限公司	用于炎症的化合物
US20230158102A1 (en)	2020-03-02	2023-05-25	Pharma Mar, S.A.	Compounds for use in the treatment of coronavirus infection
AU2021231521A1 (en)	2020-03-02	2022-10-06	Pharma Mar, S.A.	PLD for use in combination in the treatment of coronavirus
CN115594739B (zh) *	2021-06-28	2025-02-14	浙江珲达生物科技有限公司	一种dehydrodidemnin B类化合物的制备方法
WO2024165764A1 (en)	2023-02-10	2024-08-15	Pharma Mar, S.A.	Plitidepsin for use in the treatment of non-integrated dna viral infections

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4950649A (en)	1980-09-12	1990-08-21	University Of Illinois	Didemnins and nordidemnins
DE3161556D1 (en)	1980-09-12	1984-01-05	Univ Illinois	Novel antibiotics, derivatives thereof, processes for their extraction, and compositions containing them
US4493796A (en)	1980-09-12	1985-01-15	Board Of Trustees, Univ. Of Ill.	Didemnins A, B, C, and derivatives thereof, as antiviral agents
IT1153974B (it)	1982-09-23	1987-01-21	Erba Farmitalia	Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
US4948791A (en) *	1989-04-10	1990-08-14	The Board Of Trustees Of The University Of Illinois	Novel Cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum
GB8922026D0 (en)	1989-09-29	1989-11-15	Pharma Mar Sa	Novel anti-viral and cytotoxic agent
DE4120327A1 (de) *	1991-06-20	1992-12-24	Basf Ag	Neue peptide, ihre herstellung und verwendung
US5462726A (en)	1993-12-17	1995-10-31	Bristol-Myers Squibb Company	Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents
US5861439A (en)	1994-11-14	1999-01-19	Alza Corporation	Method for enhanced electrotransport agent delivery
US6509316B2 (en) *	1995-03-07	2003-01-21	George Washington University	Pharmaceutical compositions, methods, and kits for treatment and diagnosis of lung cancer
ES2102322B1 (es) *	1995-07-13	1998-03-01	Pharma Mar Sa	Procedimiento de preparacion de didemnina a.
ES2151277T3 (es)	1996-05-22	2000-12-16	Protarga Inc	Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere.
US6156724A (en)	1996-06-07	2000-12-05	Rinehart; Kenneth L.	Uses of didemnins as immunomodulating agents
US6380156B1 (en) *	1996-10-24	2002-04-30	The Board Of Trustees Of The University Of Illnois	Total synthesis of the amino hip analogue of didemnin A
DE69735583T2 (de) *	1996-10-24	2007-04-05	The Board Of Trustees Of The University Of Illinois, Urbana	Semisynthetisches verfahren zur herstellung von didemninanalogen
US6034058A (en)	1997-04-15	2000-03-07	Rinehart; Kenneth L.	Semi-synthetic alanyl dilemnin analogs
US6030943A (en)	1997-05-07	2000-02-29	Crumb; William J.	Dehydrodidemnin B as an L-type calcium channel enhancer
GB9803448D0 (en)	1998-02-18	1998-04-15	Pharma Mar Sa	Pharmaceutical formulation
CA2338638C (en)	1998-07-30	2009-03-17	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
US6890904B1 (en)	1999-05-25	2005-05-10	Point Therapeutics, Inc.	Anti-tumor agents
AU781897B2 (en)	1999-05-25	2005-06-23	Point Therapeutics, Inc.	Anti-tumor comprising boroproline compounds
CZ302498B6 (cs)	1999-11-15	2011-06-15	Pharma Mar, S. A.	Farmaceutický prípravek obsahující aplidin pro lécení rakovinových onemocnení
CA2405779A1 (en)	2000-04-07	2001-10-18	The Trustees Of The University Of Pennsylvania	Tamandarin and didemnin analogs and methods of making and using them
US6509315B1 (en) *	2000-04-07	2003-01-21	The Trustees Of The University Of Pennsylvania	Didemnin analogs and fragments and methods of making and using them
UA76718C2 (uk) *	2000-06-30	2006-09-15	Фарма Мар, С.А.	Протипухлинні похідні аплідину
MXPA03003230A (es)	2000-10-12	2004-12-03	Pharma Mar Sa	Tratamiento de canceres.
DE60229414D1 (de)	2001-10-19	2008-11-27	Pharma Mar Sa	Verwendung von aplidine in der behandlung von pankreaskrebs
EP1620117A4 (en)	2003-03-12	2009-07-29	Pharma Mar Sa	IMPROVED ANTITUMORAL TREATMENTS

2001
- 2001-02-07 UA UA2003010794A patent/UA76718C2/uk unknown
- 2001-07-02 AT AT01945484T patent/ATE393775T1/de active
- 2001-07-02 KR KR1020027018030A patent/KR100866056B1/ko not_active Expired - Lifetime
- 2001-07-02 AU AU6769801A patent/AU6769801A/xx active Pending
- 2001-07-02 NZ NZ52336701A patent/NZ523367A/xx not_active IP Right Cessation
- 2001-07-02 CZ CZ2002-4233A patent/CZ304204B6/cs not_active IP Right Cessation
- 2001-07-02 HU HU0301387A patent/HU228998B1/hu unknown
- 2001-07-02 US US10/312,341 patent/US7348310B2/en not_active Expired - Lifetime
- 2001-07-02 CN CN01814701A patent/CN1449408A/zh active Pending
- 2001-07-02 SI SI200130843T patent/SI1294747T1/sl unknown
- 2001-07-02 DK DK01945484T patent/DK1294747T3/da active
- 2001-07-02 EP EP01945484A patent/EP1294747B1/en not_active Expired - Lifetime
- 2001-07-02 PT PT01945484T patent/PT1294747E/pt unknown
- 2001-07-02 IL IL15368001A patent/IL153680A0/xx unknown
- 2001-07-02 BR BR0112375A patent/BRPI0112375B8/pt not_active IP Right Cessation
- 2001-07-02 JP JP2002507848A patent/JP5289662B2/ja not_active Expired - Lifetime
- 2001-07-02 ES ES01945484T patent/ES2305083T3/es not_active Expired - Lifetime
- 2001-07-02 PL PL360531A patent/PL208651B1/pl unknown
- 2001-07-02 DE DE60133817T patent/DE60133817T2/de not_active Expired - Lifetime
- 2001-07-02 HK HK03105236.0A patent/HK1052940B/en not_active IP Right Cessation
- 2001-07-02 CN CN201410805461.6A patent/CN104650177A/zh active Pending
- 2001-07-02 MX MXPA03000202A patent/MXPA03000202A/es active IP Right Grant
- 2001-07-02 CA CA2414609A patent/CA2414609C/en not_active Expired - Lifetime
- 2001-07-02 WO PCT/GB2001/002901 patent/WO2002002596A2/en not_active Ceased
2002
- 2002-12-26 IL IL153680A patent/IL153680A/en active IP Right Grant
- 2002-12-27 NO NO20026242A patent/NO334096B1/no not_active IP Right Cessation
2007
- 2007-04-20 US US11/788,866 patent/US7678765B2/en not_active Expired - Lifetime
2008
- 2008-07-30 CY CY20081100795T patent/CY1108549T1/el unknown

Also Published As

Publication number	Publication date
JP5289662B2 (ja)	2013-09-11
CZ304204B6 (cs)	2014-01-02
HUP0301387A3 (en)	2005-04-28
IL153680A0 (en)	2003-07-06
EP1294747A2 (en)	2003-03-26
BRPI0112375B8 (pt)	2021-05-25
BRPI0112375B1 (pt)	2020-12-01
WO2002002596A3 (en)	2002-05-23
CN1449408A (zh)	2003-10-15
KR100866056B1 (ko)	2008-10-30
SI1294747T1 (sl)	2008-12-31
IL153680A (en)	2012-05-31
BR0112375A (pt)	2003-06-24
KR20030013477A (ko)	2003-02-14
ATE393775T1 (de)	2008-05-15
DE60133817D1 (de)	2008-06-12
ES2305083T3 (es)	2008-11-01
CN104650177A (zh)	2015-05-27
UA76718C2 (uk)	2006-09-15
MXPA03000202A (es)	2003-10-15
DK1294747T3 (da)	2008-10-27
CY1108549T1 (el)	2014-04-09
NO334096B1 (no)	2013-12-09
PT1294747E (pt)	2008-08-08
HK1052940A1 (en)	2003-10-03
HUP0301387A2 (hu)	2003-08-28
CA2414609C (en)	2012-04-24
CZ20024233A3 (cs)	2003-06-18
JP2004502702A (ja)	2004-01-29
EP1294747B1 (en)	2008-04-30
US7678765B2 (en)	2010-03-16
NZ523367A (en)	2004-12-24
AU6769801A (en)	2002-01-14
NO20026242L (no)	2003-02-27
US20080009435A1 (en)	2008-01-10
HK1052940B (en)	2008-10-24
WO2002002596A2 (en)	2002-01-10
US7348310B2 (en)	2008-03-25
HU228998B1 (en)	2013-07-29
CA2414609A1 (en)	2002-01-10
PL208651B1 (pl)	2011-05-31
DE60133817T2 (de)	2009-05-20
US20040097413A1 (en)	2004-05-20
NO20026242D0 (no)	2002-12-27

Legal Events

Date	Code	Title	Description
2012-01-31	RECP	Rectifications of patent specification

Publication	Publication Date	Title
NZ523367A (en)	2004-12-24	Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
SG149063A1 (en)	2009-01-29	Use of modified cyclosporins for the treatment of hcv disorders
TW200510325A (en)	2005-03-16	2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
PH12013500123A1 (en)	2015-10-26	Hemiasterlin derivatives and uses thereof
IS6655A (is)	2002-12-12	Sýklópentanóindól, efnablöndur sem innihalda slíkefnasambönd og meðhöndlunaraðferðir
HRP20010738B1 (en)	2005-02-28	N-cyanomethyl amides as protease inhibitors
PL344475A1 (en)	2001-11-05	Bridged indenopyrrolocarbazoles
AU3831301A (en)	2001-08-27	Method for treating ocular pain
BG107220A (en)	2003-05-30	Antitumoral ecteinascudin derivatives
PL371127A1 (pl)	2005-06-13	Pochodne 6-amino-morfinianu, metody ich otrzymywania oraz ich zastosowania
IL163026A (en)	2009-09-01	Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
IL171974A0 (en)	2006-04-10	Tetrahydrocarbazole derivatives and their pharmaceutical use
WO2002010152A3 (de)	2002-08-01	Neue indolderivate und deren verwendung als arzneimittel
MXPA04000506A (es)	2004-07-23	Nuevos derivados de et-743 antitumorales.
MXPA04004090A (es)	2004-07-08	Compuestos substituidos de 1h-quinolin-2-ona.
EP1436279A4 (en)	2005-10-26	CHEMICAL COMPOUNDS
MXPA04004757A (es)	2004-08-02	Uso de una ascomicina para el tratamiento de blefaritis.
MXPA03005400A (es)	2004-09-06	Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
DE60120398D1 (de)	2006-07-20	Imidazopyridin-8-one
AU2002359762A1 (en)	2003-07-24	Luminacin analogs and uses thereof
UA49216A (uk)	2002-09-16	Засіб для лікування ускладнень після видалення злоякісних новоутворень шкіри
TW200635951A (en)	2006-10-16	Specific binding agents of human angiopoietin-2